<i>Salmonella-related</i> mycotic pseudoaneurysm

Nseir, Bacel; Cutrona, Anthony

doi:10.3949/ccjm.76a.08031

Cited by 4 publications

(3 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The cases reported in the literature are summarized in Supplementary Table S1 (refs. 22 – 56 ). The clinical features of the 4 cases treated at our hospital and the 53 cases reported in the literature are summarized in Table 1 .…”

Section: Resultsmentioning

confidence: 99%

Mycotic aneurysm due to Salmonella species: clinical experiences and review of the literature

Guo

Bai

Yang

et al. 2018

Braz J Med Biol Res

View full text Add to dashboard Cite

The mortality of patients with mycotic aneurysms is high, especially in East Asia, and infection by Salmonella species is the most common. Our study aimed to improve prognosis of adult mycotic aneurysms with early diagnosis and accurate treatment. Four adult patients with mycotic aneurysm caused by Salmonella were included and analyzed by single-center retrospective analysis. Cases reported in the literature during the past 10 years were also summarized. The average age of the 4 male patients was 61.25 years, while that of the 53 cases reported in the literature was 65.13 years. Hypertension, diabetes, and atherosclerosis were common complications. Most patients presented fever and experienced pain at the corresponding position of the aneurysm. Laboratory examination found an increased number of white blood cells accompanied by an increase in inflammatory markers. Most aneurysms were found in the abdominal aorta, while the rupture of an aneurysm was the most common complication. The mortality rates were 21.43 and 7.14% after open surgery or endovascular aneurysm repair (EVAR) intervention, respectively. The recurrence rates of infection were 0 and 17.85% for both treatments, respectively. The mortality rate of mycotic aneurysm caused by Salmonella infection was high in middle-aged males with hypertension, diabetes, and atherosclerosis. The possibility of a Salmonella-infected aneurysm should be considered in these high-risk groups presenting chills, fever, chest, and back pain. Open surgery was superior to EVAR treatment in the clearance of infected foci and the reduction of postoperative recurrence. The recurrence of postoperative infection can be prevented by intravenous antibiotic therapy for 6 weeks post-surgery.

show abstract

Section: Resultsmentioning

confidence: 99%

Mycotic aneurysm due to Salmonella species: clinical experiences and review of the literature

Guo

Bai

Yang

et al. 2018

Braz J Med Biol Res

View full text Add to dashboard Cite

show abstract

“…Independent of immunosuppressive disorders, a 6-8-week course of antibiotics is recommended and prophylactic cholecystectomy must be considered. 9 Illicit drug use is implicated in the development of mycotic aneurysm. The condition occurs more commonly in the lower extremities if the patient has used their leg veins in an attempt to conceal needle puncture marks, or following previous thrombosis or sclerosis of the arm veins.…”

Section: Discussionmentioning

confidence: 99%

Salmonella-related mycotic pseudoaneurysm of the superficial femoral artery

Cury

Campos

Santos

2012

International Journal of Surgery Case Reports

View full text Add to dashboard Cite

Arterial infection is associated with immunosuppressive states and Staphylococcus aureus is the most commonly isolated organism in mycotic aneurysms. Also, Escherichia coli, Salmonella sp. and anaerobic species have been identified. Salmonella species are associated with mycotic aneurysms in the abdominal aorta and the use of autogenous vein grafts is the standard treatment for this condition. In lower extremities, autogenous conduits have been already used with good results of patency and freedom from re-infection. Endovascular treatment is a feasible approach in these situations, but there is not reports regarding long term results and this treatment is occasionally associated with prosthesis infection.

show abstract

“…3 Mycotic aneurysm is a rare and fatal disease that can be divided into a true aneurysm or a pseudoaneurysm. 4 After the artery is damaged, blood flows out of the arterial wall, forming a local hematoma on the arterial wall. The local fibrous tissue wraps around it to form a false lumen, which is clinically called a pseudoaneurysm.…”

Section: Introductionmentioning

confidence: 99%

Mycotic Pseudoaneurysm of Thoracic Aortic Caused by Salmonella Paratyphi A: A Case Report

Han¹,

Zhang²,

Gong³

et al. 2023

IDR

View full text Add to dashboard Cite

Background Mycotic pseudoaneurysm, also known as infectious pseudoaneurysm, is a severe disease with a high mortality rate. Although Salmonella infection is a common etiological factor for mycotic pseudoaneurysm, Salmonella paratyphi A infection causing mycotic pseudoaneurysm is extremely rare. Endovascular therapy has been described as a feasible treatment for mycotic pseudoaneurysm. Case Presentation A 63-year-old female patient had a thoracic aortic pseudoaneurysm caused by Salmonella paratyphi A infection. The patient associated with diabetes had a fever, abdominal pain, and low back pain, who was successfully treated using endovascular stents treatment and antibiotics. Conclusion Salmonella paratyphi A is a bloodstream infection bacterium with the ability to cause mycotic pseudoaneurysm. To treat mycotic pseudoaneurysms of the thoracic aorta, endovascular stent-graft treatment combined with antibiotics is an alternative treatment for patients who cannot tolerate open surgery.

show abstract

Salmonella-related mycotic pseudoaneurysm

Cited by 4 publications

References 7 publications

Mycotic aneurysm due to Salmonella species: clinical experiences and review of the literature

Mycotic aneurysm due to Salmonella species: clinical experiences and review of the literature

Salmonella-related mycotic pseudoaneurysm of the superficial femoral artery

Mycotic Pseudoaneurysm of Thoracic Aortic Caused by Salmonella Paratyphi A: A Case Report

Contact Info

Product

Resources

About